NSEAnalysts/Institutional Investor Meet/Con. Call Updates29 Oct 2026 · 29 Oct 2026, 05:17 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Eris Lifesciences Limited · ERIS
✦ AI SummaryResults
Eris Lifesciences Limited has informed the Exchange about the availability of the transcript of the Analyst and Investor call held after the announcement of financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Limited has informed the Exchange about Transcript
Attachments (1)
📄pdf
Download →
ERIS_29102026171716_intimationsigned.pdf
View document text
Date: 29 October 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai – 400001 Bandra (E)
Mumbai – 400051
Security Code: 540596 Symbol: ERIS
SUBJECT: TRANSCRIPT OF ANALYST AND INVESTOR CALL
Dear Sir/Madam,
This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of
financial results for the quarter and half year ended September 30, 2026, is available on our website at URL
https://www.eris.co.in/investor-relations/financials/financial-results
(File name: Q2 FY27 Earnings Call Transcript).
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary and Compliance Officer
ICSI Mem. No. A26493